Your browser doesn't support javascript.
loading
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Mateos, Maria-Victoria; Weisel, Katja; Martin, Thomas; Berdeja, Jesús G; Jakubowiak, Andrzej; Stewart, A Keith; Jagannath, Sundar; Lin, Yi; Diels, Joris; Ghilotti, Francesca; Thilakarathne, Pushpike; Perualila, Nolen J; Cabrieto, Jedelyn; Haefliger, Benjamin; Erler-Yates, Nichola; Hague, Clare; Jackson, Carolyn C; Schecter, Jordan M; Strulev, Vadim; Nesheiwat, Tonia; Pacaud, Lida; Einsele, Hermann; Moreau, Philippe.
Afiliación
  • Mateos MV; University Hospital of Salamanca/IBSAL, CIC, Salamanca. mvmateos@usal.es.
  • Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg.
  • Martin T; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Berdeja JG; Sarah Cannon Research Institute, Nashville, TN.
  • Jakubowiak A; University of Chicago.
  • Stewart AK; University Health Network and the Princess Margaret Cancer Centre, Toronto, ON.
  • Jagannath S; Mount Sinai Medical Center.
  • Lin Y; Mayo Clinic, Rochester, MN.
  • Diels J; Janssen Pharmaceutica NV, Beerse.
  • Ghilotti F; Janssen-Cilag SpA, Cologno Monzese.
  • Thilakarathne P; Janssen Pharmaceutica NV, Beerse.
  • Perualila NJ; Janssen Pharmaceutica NV, Beerse.
  • Cabrieto J; Janssen Pharmaceutica NV, Beerse.
  • Haefliger B; Cilag GmbH International, Zug.
  • Erler-Yates N; Janssen-Cilag GmbH, Neuss.
  • Hague C; Janssen-Cilag N.V., High Wycombe.
  • Jackson CC; Janssen R-D, Raritan, NJ.
  • Schecter JM; Janssen R-D, Raritan, NJ.
  • Strulev V; EMEA Medical Affairs, Janssen Pharmaceutica NV, Beerse.
  • Nesheiwat T; Legend Biotech USA Inc., Piscataway, NJ.
  • Pacaud L; Legend Biotech USA Inc., Piscataway, NJ.
  • Einsele H; UniversitätsklinikumWürzburg, Medizinische Klinik und Poliklinik II, Würzburg.
  • Moreau P; ClinicalHematology, University Hospital Hotel-Dieu, Nantes.
Haematologica ; 108(8): 2192-2204, 2023 08 01.
Article en En | MEDLINE | ID: mdl-36546453
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article